ResearcherUniversidade Federal de PernambucoNo recent work listed

Antônio Felix da Silva Filho

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8685-1911; OpenAlex author ID A5021470342. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

Galectin-3 is modulated in pancreatic cancer cells under hypoxia and nutrient deprivation. Co-author DOI 10.1515/hsz-2019-0413 ↗
Patients With Pancreatic Ductal Adenocarcinoma Have High Serum Galectin-9 Levels: A Sweet Molecule to Keep an Eye On. First author DOI 10.1097/mpa.0000000000001126 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lucas B. Tavares · 2 shared papers, 2018–2020 · strength 0.24
- Paper Galectin-3 is modulated in pancreatic cancer cells under hypoxia and nutrient deprivation. DOI 10.1515/hsz-2019-0413 ↗
- Paper Patients With Pancreatic Ductal Adenocarcinoma Have High Serum Galectin-9 Levels: A Sweet Molecule to Keep an Eye On. DOI 10.1097/mpa.0000000000001126 ↗
Moacyr Jesus Barreto de Melo Rêgo · 2 shared papers, 2018–2020 · strength 0.24
- Paper Galectin-3 is modulated in pancreatic cancer cells under hypoxia and nutrient deprivation. DOI 10.1515/hsz-2019-0413 ↗
- Paper Patients With Pancreatic Ductal Adenocarcinoma Have High Serum Galectin-9 Levels: A Sweet Molecule to Keep an Eye On. DOI 10.1097/mpa.0000000000001126 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.